P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA

• C. Harrison,
• P. Bose,
• R. Mesa,
• A. Gerds,
• S. Oh,
• J.-J. Kiladjian,
• V. García-Gutierrez,
• A. Vannucchi,
• C. Scheid,
• M. Sobas,
• S. Verstovsek,
• S. Buckley,
• K. Roman-Torres,
• J. Mascarenhas

Affiliations

C. Harrison

1 Guy’s and St Thomas’ NHS Trust, London, United Kingdom

P. Bose

2 The University of Texas MD Anderson Cancer Center, Houston, TX

R. Mesa

3 UT Health San Antonio Cancer Center, San Antonio, TX

A. Gerds

4 Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

S. Oh

5 Washington University School of Medicine, St. Louis, MO, United States of America

J.-J. Kiladjian

6 Hôpital Saint-Louis, Université de Paris, Paris, France

V. García-Gutierrez

7 Hospital Universitario Ramón y Cajal, Madrid, Spain

A. Vannucchi

8 Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy

C. Scheid

9 University of Cologne, Cologne, Germany

M. Sobas

10 Wroclaw Medical University, Wroclaw, Poland

S. Verstovsek

2 The University of Texas MD Anderson Cancer Center, Houston, TX

S. Buckley

11 CTI BioPharma, Seattle, WA

K. Roman-Torres

11 CTI BioPharma, Seattle, WA

J. Mascarenhas

12 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America